KRISTEN GRABOWSKI: Open Payments
NPI 1730668377 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 49 payments from 16 companies in 2025. Trend: 2023 $597 · 2024 $939 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $187 |
| Corcept Therapeutics | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $76 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $62 |
| PFIZER INC. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $39 |
| Exact Sciences Corporation | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, Korlym, CAPLYTA, Kerendia, ISTURISA, NURTEC ODT, REXULTI, HETLIOZ.
Industry payments across VA — which companies pay providers there.
